News
FDA requests Moderna, Pfizer/BioNTech add safety warnings about myocarditis risk to COVID-19 vaccines, with specific rates ...
The FDA said it is making 'enhancements' designed to help states develop programs for importing cheaper drugs from Canada.
FTC sends new warning letters to Teva, Novartis, Amphastar, Viatris's Mylan, and Covis Pharma over allegedly improper drug ...
Eikon Therapeutics is laying off staff for the second time in 19 months, responding to 'changes in external circumstances' ...
The FDA's Oncologic Drugs Advisory Committee on Wednesday voted 5 to 4 against UroGen’s mitomycin as an option for low-grade ...
The FDA’s Oncologic Drugs Advisory Committee voted 8-0 against a new indication for Pfizer’s Talzenna in combination with Xtandi for first-line treatment of adults with … Get free ...
Genentech signs $105M upfront deal with Orionis Biosciences to develop molecular glue cancer drugs, with potential milestones ...
PureTech's deupirfenidone outperforms Roche's Esbriet in lung fibrosis trial, showing greater lung function preservation with ...
Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...
Moderna pulls BLA for its Covid-flu shot: The company suggested on its most recent … Get free access to a limited ...
Weill Cornell Medicine study shows cocaine vaccine triggers antibodies & reduces drug use in small trial, but effects modest.
Juvenescence is out with a $76 million Series B-1, its first equity funding since before the Covid-19 pandemic.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results